# Tri-omics progress

**Goal:** Build a reproducible pipeline while keeping the fasting,
diabetic-treatment and organophosphate studies, and their assay profiles,
distinct. Every published handoff must identify the evidence it actually used.

**Works now — tested on fixtures only:** Earlier analysis components and the
reviewed B-lineage repair remain integrated. M7-010's historical full source
suite passed 5,893 checks; that result does not verify the new publication split.

**Changed — reviewed decision, blocked implementation:** Astra approved M7-013's
separation of standalone C-08 endpoints from a B-backed C-06 handoff. Luna added
failing tests but made no product changes. Sol independently reproduced two
C-08 failures and ten C-06 failures. The evidence is saved, not integrated as
working code.

**Not established:** No new provenance frame, biological validation or private
study analysis. C-06 remains unaccepted for this work; C-07 is not run and C-09
remains unqualified. M7/G7 and Stage D stay closed.

**Next / Needs Omar:** A bounded disposition for the existing nested C-02
fixture: its preparation identities disagree, and native B rejects it. We did
not bypass that check or change the excluded ticket.

**Sync:** Local receipt, ledger and handover updated. No GitHub push or Notion sync.
